trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Hypertension, Pulmonary D006976 32 associated lipids
Endometriosis D004715 29 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Zhang XF et al. Novel biomolecule lycopene-reduced graphene oxide-silver nanoparticle enhances apoptotic potential of trichostatin A in human ovarian cancer cells (SKOV3). 2017 Int J Nanomedicine pmid:29075115
Dalla Pozza E et al. Trichostatin A alters cytoskeleton and energy metabolism of pancreatic adenocarcinoma cells: An in depth proteomic study. 2018 J. Cell. Biochem. pmid:29095525
Good KV et al. Trichostatin A decreases the levels of MeCP2 expression and phosphorylation and increases its chromatin binding affinity. 2017 Epigenetics pmid:29099289
Lillico R et al. Increased Post-Translational Lysine Acetylation of Myelin Basic Protein Is Associated with Peak Neurological Disability in a Mouse Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis. 2018 J. Proteome Res. pmid:29111742
Kalaiarasi A et al. Copper oxide nanoparticles induce anticancer activity in A549 lung cancer cells by inhibition of histone deacetylase. 2018 Biotechnol. Lett. pmid:29116558
Seo SK et al. Trichostatin A Induces NAG-1 Expression and Apoptosis in Human Endometriotic Stromal Cells. 2018 Reprod Sci pmid:29157123
Bagheri-Hosseinabadi Z et al. Differentiation of human adipose-derived stem cells into cardiomyocyte-like cells in fibrin scaffold by a histone deacetylase inhibitor. 2017 Biomed Eng Online pmid:29169361
Anantharaju PG et al. Induction of colon and cervical cancer cell death by cinnamic acid derivatives is mediated through the inhibition of Histone Deacetylases (HDAC). 2017 PLoS ONE pmid:29190639
Porter NJ et al. Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors. 2017 Proc. Natl. Acad. Sci. U.S.A. pmid:29203661
Wood M et al. Trichostatin A inhibits deacetylation of histone H3 and p53 by SIRT6. 2018 Arch. Biochem. Biophys. pmid:29233643
Sanaei M et al. Genistein and Trichostatin A Induction of Estrogen Receptor Alpha Gene Expression, Apoptosis and Cell Growth Inhibition in Hepatocellular Carcinoma HepG 2 Cells 2017 Asian Pac. J. Cancer Prev. pmid:29286617
Chan ST et al. Quercetin enhances the antitumor effect of trichostatin A and suppresses muscle wasting in tumor-bearing mice. 2018 Food Funct pmid:29292417
Wu Y et al. Regulatory Roles of Histone Deacetylases 1 and 2 in Pb-induced Neurotoxicity. 2018 Toxicol. Sci. pmid:29301062
Bodas M et al. Inhibition of histone-deacetylase activity rescues inflammatory cystic fibrosis lung disease by modulating innate and adaptive immune responses. 2018 Respir. Res. pmid:29301535
Cribbs A et al. Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cells. 2018 J. Biol. Chem. pmid:29301935
Tiffon C Histone Deacetylase Inhibition Restores Expression of Hypoxia-Inducible Protein NDRG1 in Pancreatic Cancer. 2018 Pancreas pmid:29303911
Gao L et al. Histone deacetylase inhibitor trichostatin A and autophagy inhibitor chloroquine synergistically exert anti-tumor activity in H-ras transformed breast epithelial cells. 2018 Mol Med Rep pmid:29344672
Cai MH et al. Depletion of HDAC1, 7 and 8 by Histone Deacetylase Inhibition Confers Elimination of Pancreatic Cancer Stem Cells in Combination with Gemcitabine. 2018 Sci Rep pmid:29374219
Gurgul A et al. Evaluation of changes arising in the pig mesenchymal stromal cells transcriptome following cryopreservation and Trichostatin A treatment. 2018 PLoS ONE pmid:29390033
Zhang X et al. Tyrphostin B42 attenuates trichostatin A-mediated resistance in pancreatic cancer cells by antagonizing IL-6/JAK2/STAT3 signaling. 2018 Oncol. Rep. pmid:29393444
Jayaraman A et al. Amelioration of progressive autoimmune encephalomyelitis by epigenetic regulation involves selective repression of mature neutrophils during the preclinical phase. 2018 Exp. Neurol. pmid:29453977
Motawi TK et al. Combinatorial strategy of epigenetic and hormonal therapies: A novel promising approach for treating advanced prostate cancer. 2018 Life Sci. pmid:29455003
Sun P et al. Effect of trichostatin A on Burkitt's lymphoma cells: Inhibition of EPS8 activity through Phospho-Erk1/2 pathway. 2018 Biochem. Biophys. Res. Commun. pmid:29462617
Jang BG et al. Trichostatin A and Sirtinol Regulate the Expression and Nucleocytoplasmic Shuttling of Histone Deacetylases in All-Trans Retinoic Acid-Induced Differentiation of Neuroblastoma Cells. 2018 J. Mol. Neurosci. pmid:29516351
Lu Y and Zhang K Cellular Reprogramming in the Retina - Seeing the Light. 2018 N. Engl. J. Med. pmid:29539280
Palazzese L et al. Nuclear quiescence and histone hyper-acetylation jointly improve protamine-mediated nuclear remodeling in sheep fibroblasts. 2018 PLoS ONE pmid:29543876
Shi Y et al. Histone deacetylase inhibitors alter the expression of molecular markers in breast cancer cells via microRNAs. 2018 Int. J. Mol. Med. pmid:29620153
Li Q et al. Bisphenol A and Phthalates Modulate Peritoneal Macrophage Function in Female Mice Involving SYMD2-H3K36 Dimethylation. 2018 Endocrinology pmid:29718165
Azuma R et al. Combinational Treatment of Trichostatin A and Vitamin C Improves the Efficiency of Cloning Mice by Somatic Cell Nuclear Transfer. 2018 J Vis Exp pmid:29757287
Wang JH et al. HDAC inhibitors, trichostatin A and valproic acid, increase E‑cadherin and vimentin expression but inhibit migration and invasion of cholangiocarcinoma cells. 2018 Oncol. Rep. pmid:29767267
Liu M et al. Decreased H3K9ac level of StAR mediated testicular dysplasia induced by prenatal dexamethasone exposure in male offspring rats. 2018 Toxicology pmid:29902490
Rahimian A et al. [Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism]. Mol. Biol. (Mosk.) pmid:29989579
Lugenbiel P et al. Inhibition of Histone Deacetylases Induces K+ Channel Remodeling and Action Potential Prolongation in HL-1 Atrial Cardiomyocytes. 2018 Cell. Physiol. Biochem. pmid:30134221
Feng Y et al. Short-Chain Fatty Acids Manifest Stimulative and Protective Effects on Intestinal Barrier Function Through the Inhibition of NLRP3 Inflammasome and Autophagy. 2018 Cell. Physiol. Biochem. pmid:30138914
Mazzio EA and Soliman KFA Whole-transcriptomic Profile of SK-MEL-3 Melanoma Cells Treated with the Histone Deacetylase Inhibitor: Trichostatin A. Cancer Genomics Proteomics pmid:30194076
Wang Y et al. Inhibition of Histone Deacetylases Prevents Cardiac Remodeling After Myocardial Infarction by Restoring Autophagosome Processing in Cardiac Fibroblasts. 2018 Cell. Physiol. Biochem. pmid:30235443
Jang B et al. Trichostatin A induces apoptosis in oral squamous cell carcinoma cell lines independent of hyperacetylation of histones. 2018 J Cancer Res Ther pmid:30249871
Cheng YW et al. The histone deacetylase inhibitor panobinostat exerts anticancer effects on esophageal squamous cell carcinoma cells by inducing cell cycle arrest. 2018 Cell Biochem. Funct. pmid:30484863
Yoshida M and Beppu T Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin A. 1988 Exp. Cell Res. pmid:3134246
Corelli F et al. [Antibacterial and antifungal compounds. VIII. Synthesis and antifungal activity of pyrrol derivatives similar to trichostatin A]. 1987 Farmaco Sci pmid:3329612
Otoguro K et al. Screening for new antitrichomonal substances of microbial origin and antitrichomonal activity of trichostatin A. 1988 J. Antibiot. pmid:3372352
Miyashita T et al. Activation of the mouse cytokeratin A (endo A) gene in teratocarcinoma F9 cells by the histone deacetylase inhibitor Trichostatin A. 1994 FEBS Lett. pmid:7523197
Worrad DM et al. Temporally restricted spatial localization of acetylated isoforms of histone H4 and RNA polymerase II in the 2-cell mouse embryo. 1995 Development pmid:7555721
Arts J et al. Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation. 1995 Biochem. J. pmid:7646441
O'Neill LP and Turner BM Histone H4 acetylation distinguishes coding regions of the human genome from heterochromatin in a differentiation-dependent but transcription-independent manner. 1995 EMBO J. pmid:7664735
Futamura M et al. Trichostatin A inhibits both ras-induced neurite outgrowth of PC12 cells and morphological transformation of NIH3T3 cells. 1995 Oncogene pmid:7700637
Yoshida M et al. Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. 1995 Bioessays pmid:7786288
Thompson EM et al. Real time imaging of transcriptional activity in live mouse preimplantation embryos using a secreted luciferase. 1995 Proc. Natl. Acad. Sci. U.S.A. pmid:7877974
Girardot V et al. Relationship between core histone acetylation and histone H1(0) gene activity. 1994 Eur. J. Biochem. pmid:7925412
Almouzni G et al. Histone acetylation influences both gene expression and development of Xenopus laevis. 1994 Dev. Biol. pmid:7958429
Sanchez del Pino MM et al. Properties of the yeast nuclear histone deacetylase. 1994 Biochem. J. pmid:7980438
Kimura M et al. Dual modes of action of platelet-derived growth factor and its inhibition by trichostatin-A for DNA synthesis in primary cultured smooth muscle cells of rat aorta. 1994 Biol. Pharm. Bull. pmid:8019505
Hoshikawa Y et al. Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines. 1994 Exp. Cell Res. pmid:8082721
Kijima M et al. Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. 1993 J. Biol. Chem. pmid:8226751
Taunton J et al. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. 1996 Science pmid:8602529
Van Lint C et al. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. 1996 EMBO J. pmid:8605881
Carmen AA et al. HDA1 and HDA3 are components of a yeast histone deacetylase (HDA) complex. 1996 J. Biol. Chem. pmid:8663039
Takahashi I et al. Selective inhibition of IL-2 gene expression by trichostatin A, a potent inhibitor of mammalian histone deacetylase. 1996 J. Antibiot. pmid:8682722
Van Lint C et al. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. 1996 Gene Expr. pmid:8723390
Ogryzko VV et al. Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. 1996 Mol. Cell. Biol. pmid:8756678
Okabe M et al. Competence effect of PDGF on Ki-67 antigen and DNA contents, and its inhibition by trichostatin-A and a butylydene phthalide BP-421 in primary smooth muscle cells of rat aorta by flow cytometry. 1995 Biol. Pharm. Bull. pmid:8787785
Yamamoto I et al. Histone hyperacetylation plays a role in augmentation of IL-4-induced IgE production in LPS-stimulated murine B-lymphocytes by sodium butyrate. 1996 J. Biochem. pmid:8827437
Bartsch J et al. Moderate increase in histone acetylation activates the mouse mammary tumor virus promoter and remodels its nucleosome structure. 1996 Proc. Natl. Acad. Sci. U.S.A. pmid:8855250
Yoshida M [Molecular targets of cell cycle inhibitors and their mode of action]. 1996 Tanpakushitsu Kakusan Koso pmid:8890633
Lee E et al. Involvement of histone hyperacetylation in triggering DNA fragmentation of rat thymocytes undergoing apoptosis. 1996 FEBS Lett. pmid:8898091
Zhang J et al. Basis for the loss of aryl hydrocarbon receptor gene expression in clones of a mouse hepatoma cell line. 1996 Mol. Pharmacol. pmid:8967965
Huang N et al. Inhibition of IL-8 gene expression in Caco-2 cells by compounds which induce histone hyperacetylation. 1997 Cytokine pmid:9067093
Sano M and Kitajima S Inhibition of the nerve growth factor-induced outgrowth of neurites by trichostatin A requires protein synthesis de novo in PC12D cells. 1996 Brain Res. pmid:9117395
Nagy L et al. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. 1997 Cell pmid:9150137
Garcia-Villalba P et al. Histone acetylation influences thyroid hormone and retinoic acid-mediated gene expression. 1997 DNA Cell Biol. pmid:9150429
Chen WY et al. Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase. 1997 Proc. Natl. Acad. Sci. U.S.A. pmid:9159154
Dion LD et al. Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase. 1997 Virology pmid:9168882
Xu L et al. Effect of the histone deacetylase inhibitor trichostatin A on the responsiveness of rat hepatocytes to dioxin. 1997 Biochem. Pharmacol. pmid:9174108
Sommer A et al. Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity. 1997 Curr. Biol. pmid:9197243
Stein P et al. Stage-dependent redistributions of acetylated histones in nuclei of the early preimplantation mouse embryo. 1997 Mol. Reprod. Dev. pmid:9211426
McBain JA et al. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. 1997 Biochem. Pharmacol. pmid:9214697
Jenster G et al. Steroid receptor induction of gene transcription: a two-step model. 1997 Proc. Natl. Acad. Sci. U.S.A. pmid:9223281
Chen ZJ and Pikaard CS Epigenetic silencing of RNA polymerase I transcription: a role for DNA methylation and histone modification in nucleolar dominance. 1997 Genes Dev. pmid:9284051
Medina V et al. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. 1997 Cancer Res. pmid:9288776
Ohno Y et al. Macrophage inflammatory protein-2: chromosomal regulation in rat small intestinal epithelial cells. 1997 Proc. Natl. Acad. Sci. U.S.A. pmid:9294201
Minucci S et al. A histone deacetylase inhibitor potentiates retinoid receptor action in embryonal carcinoma cells. 1997 Proc. Natl. Acad. Sci. U.S.A. pmid:9326603
Goldman MA Executive decision: chromatin structure and gene regulation. 1997 Trends Genet. pmid:9351338
Svensson K et al. The paternal allele of the H19 gene is progressively silenced during early mouse development: the acetylation status of histones may be involved in the generation of variegated expression patterns. 1998 Development pmid:9389664
Sowa Y et al. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites. 1997 Biochem. Biophys. Res. Commun. pmid:9405248
Sheridan PL et al. Histone acetyltransferases regulate HIV-1 enhancer activity in vitro. 1997 Genes Dev. pmid:9407026
Ekwall K et al. Transient inhibition of histone deacetylation alters the structural and functional imprint at fission yeast centromeres. 1997 Cell pmid:9428524
Wong J et al. Distinct requirements for chromatin assembly in transcriptional repression by thyroid hormone receptor and histone deacetylase. 1998 EMBO J. pmid:9430643
Llorente A et al. Expression of mutant dynamin inhibits toxicity and transport of endocytosed ricin to the Golgi apparatus. 1998 J. Cell Biol. pmid:9456316
Magnaghi-Jaulin L et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. 1998 Nature pmid:9468140
Lin RJ et al. Role of the histone deacetylase complex in acute promyelocytic leukaemia. 1998 Nature pmid:9486654
Grignani F et al. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. 1998 Nature pmid:9486655
Emiliani S et al. Characterization of a human RPD3 ortholog, HDAC3. 1998 Proc. Natl. Acad. Sci. U.S.A. pmid:9501169
Richon VM et al. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. 1998 Proc. Natl. Acad. Sci. U.S.A. pmid:9501205
Belyaev ND et al. The acetylation patterns of histones H3 and H4 along Vicia faba chromosomes are different. 1998 Chromosome Res. pmid:9510512
Komatsu Y and Hayashi H Histone deacetylase inhibitors up-regulate the expression of cell surface MHC class-I molecules in B16/BL6 cells. 1998 J. Antibiot. pmid:9531994
El Kharroubi A et al. Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter. 1998 Mol. Cell. Biol. pmid:9566873
Gray SG and Ekström TJ Effects of cell density and trichostatin A on the expression of HDAC1 and p57Kip2 in Hep 3B cells. 1998 Biochem. Biophys. Res. Commun. pmid:9571167
Koguchi Y et al. Trichostatin A and herboxidiene up-regulate the gene expression of low density lipoprotein receptor. 1997 J. Antibiot. pmid:9592573
Walia H et al. Histone acetylation is required to maintain the unfolded nucleosome structure associated with transcribing DNA. 1998 J. Biol. Chem. pmid:9603965
Nan X et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. 1998 Nature pmid:9620804